Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|September 5, 2014
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndromeM F Dawwas, G P AithalAlimentary Pharmacology & Therapeutics|July 27, 2001
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatmentG P Aithal, J C MansfieldJournal of Hepatology|December 29, 2000
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactionsG P Aithal, M D Rawlins, C P DayEndoscopy|April 3, 2009
Endoscopic-ultrasound-guided mural trucut biopsy in the investigation of unexplained thickening of esophagogastric wallT Thomas, P V Kaye, K Ragunath, et al.Alimentary Pharmacology & Therapeutics|January 9, 2013
Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver diseaseV Subramanian, R D Johnston, P Kaye, et al.Pharmacopsychiatry|January 1, 1994
Expression cloning of a serotonin transporter: a new way to study antidepressant drugsB J HoffmanCurrent Protocols in Neuroscience|April 23, 2008
cDNA expression cloning in mammalian cellsB J HoffmanClinical Pharmacology and Therapeutics|May 20, 2011
The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactionsM Pirmohamed, G P Aithal, E Behr, et al.Alimentary Pharmacology & Therapeutics|November 6, 2010
The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort studyK M Fleming, G P Aithal, T R Card, et al.Alimentary Pharmacology & Therapeutics|February 2, 2017
Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort studyJ West, T R Card, G P Aithal, et al.Pageof 14